Not Logged In

IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology worldwide. It provides ophthalmology products that are used in the treatment of serious eye diseases, such as diabetic retinopathy, glaucoma, and age-related macular degeneration. The company's ophthalmic products include consoles, including visible (yellow) photocoagulator, visible (green) photocoagulator, infrared photocoagulator, and micropulse enabled consoles; and multi-wavelength laser system configurations. It also provides ophthalmic delivery devices and other products, such as TxCell scanning laser delivery systems; TruFocus laser indirect ophthalmoscopes; slit lamp adapters; operating microscope adapters; EndoProbe, a fiber optic delivery device; G-Probe, a sterile consumable multi-use product; and DioPexy Probe, a hand-held instrument that is used in procedures to treat retinal tears and breaks. In addition, the company's ophthalmic delivery devices and other products comprise GreenTip Soft Tip Cannula, a sterile disposable that allows surgeons to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure; and MoistAir in-line air humidifier, which connects to the air line and provides humidified air to the eye during fluid air exchange. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It sells and markets its products through a direct sales force in the United States and through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.